| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |